Profil
Dr. Charlie N.
Fong joined BDC Venture Capital in 1998.
His experience in the pharmaceutical industry encompasses drug discovery, clinical development, marketing, sales training, medical education, business development, strategic partnerships, intellectual property protection, and bioinformatics.
He has held management positions with P&L, for a division of 70 people.
Prior to joining the BDC, Dr. Fong had 10 years of industrial experience with a multinational pharmaceutical company as well as start ups.
Dr. Fong has post-doctoral training from the University of California, Berkeley.
Postes actifs de Charlie N. Fong
| Sociétés | Poste | Début |
|---|---|---|
BDC Venture Capital
BDC Venture Capital Investment ManagersFinance BDC Venture Capital invests in companies located in Canada. The firm targets companies operating in the fields of life sciences, telecommunications, information technology, energy, environment, electronics and materials. It provides financing for early and growth stage capital requirements. | Private Equity Investor | 01/01/1998 |
Anciens postes connus de Charlie N. Fong
| Sociétés | Poste | Fin |
|---|---|---|
Topigen Pharmaceuticals, Inc.
Topigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for respiratory diseases | Directeur/Membre du Conseil | - |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and develops drugs | Directeur/Membre du Conseil | - |
Formation de Charlie N. Fong
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
BDC Venture Capital
BDC Venture Capital Investment ManagersFinance BDC Venture Capital invests in companies located in Canada. The firm targets companies operating in the fields of life sciences, telecommunications, information technology, energy, environment, electronics and materials. It provides financing for early and growth stage capital requirements. | Finance |
University of Ottawa
University of Ottawa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and develops drugs | Health Technology |
Topigen Pharmaceuticals, Inc.
Topigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for respiratory diseases | Health Technology |
















